A LABOUR government would circumvent any risk to patients’ treatment after Brexit by seeking to remain part of the European Medicines Agency.
Shadow health secretary Jonathan Ashworth will announce the plan in Brussels today as part Labour’s push to build links with EU figures.
“Labour will not sign off on a Brexit deal that turns the clock back on medical innovation or sees patients in the UK having to wait longer to get access to life-changing treatments,” Mr Ashworth will say. “It is a red line for me and it is red line for the Labour Party.”
Half of Britain’s medicines go to France, Germany and the Netherlands. Every month, 45 million packs are exported from Britain to the EU and 37m imported.
Britain also has the highest number of phase-one clinical trials across the EU, especially for rare and childhood diseases.
After Brexit, some new medicines could never be marketed in Britain and the average delay in submission of new medicine marketing authorisations could be up to three months, Mr Ashworth will say. For instance, Switzerland, which is not part of the agency, gets access to new medicines an average of 157 days later than EU nations.
Other commitments include protecting NHS workers who are European Economic Area (EEA) nationals, and ensuring the NHS and care sector can recruit more staff in the future.
Labour will also seek to prioritise the negotiation of continued access to existing reciprocal healthcare schemes with EEA countries or the creation of comparable alternatives.
You can’t buy a revolution, but you can help the only daily paper in Britain that’s fighting for one by joining the 501 club.
Just £5 a month gives you the opportunity to win one of 17 prizes, from £25 to the £501 jackpot.
By becoming a 501 Club member you are helping the Morning Star cover its printing, distribution and staff costs — help keep our paper thriving by joining!
You can’t buy a revolution, but you can help the only daily paper in Britain that’s fighting for one by become a member of the People’s Printing Press Society.
The Morning Star is a readers’ co-operative, which means you can become an owner of the paper too by buying shares in the society.
Shares are £1 each — though unlike capitalist firms, each shareholder has an equal say. Money from shares contributes directly to keep our paper thriving.
Some union branches have taken out shares of over £500 and individuals over £100.
You can’t buy a revolution, but you can help the only daily paper in Britain that’s fighting for one by donating to the Fighting Fund.
The Morning Star is unique, as a lone socialist voice in a sea of corporate media. We offer a platform for those who would otherwise never be listened to, coverage of stories that would otherwise be buried.
The rich don’t like us, and they don’t advertise with us, so we rely on you, our readers and friends. With a regular donation to our monthly Fighting Fund, we can continue to thumb our noses at the fat cats and tell truth to power.
Donate today and make a regular contribution.